Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent. https://t.co/AZOXN5HIHA
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung cancer treated with surgery or radiotherapy with curative intent https://t.co/9A7cZJqkQb https://t.co/kf7qAGGX7q
RT @CochraneUK: Current #CochraneEvidence suggests a survival benefit from adding #immunotherapy (excluding checkpoint inhibitors) to conve…
RT @CochraneLibrary: Current #CochraneEvidence suggests a survival benefit from adding #immunotherapy (excluding checkpoint inhibitors) to…
RT @CochraneLibrary: Current #CochraneEvidence suggests a survival benefit from adding #immunotherapy (excluding checkpoint inhibitors) to…
Immunotherapy (excluding checkpoint inhibitors) for stage I to III non-small cell lung… https://t.co/lECoNO7TMk
Current #CochraneEvidence suggests a survival benefit from adding #immunotherapy (excluding checkpoint inhibitors) to conventional curative surgery or radiotherapy for patients with localised non-small cell lung cancer (stages I to III): https://t.co/CuGMm